0002054934-25-000002.txt : 20250417 0002054934-25-000002.hdr.sgml : 20250417 20250417155154 ACCESSION NUMBER: 0002054934-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250417 DATE AS OF CHANGE: 20250417 EFFECTIVENESS DATE: 20250417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zero Point Five Therapeutics, Inc. CENTRAL INDEX KEY: 0001985295 ORGANIZATION NAME: EIN: 844255636 STATE OF INCORPORATION: DC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-543974 FILM NUMBER: 25847101 BUSINESS ADDRESS: STREET 1: 915 S. EATON STREET CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 301-327-0118 MAIL ADDRESS: STREET 1: 915 S. EATON STREET CITY: BALTIMORE STATE: MD ZIP: 21224 D 1 primary_doc.xml X0708 D LIVE 0001985295 Zero Point Five Therapeutics, Inc. 915 S. EATON STREET BALTIMORE MD MARYLAND 21224 301-327-0118 DISTRICT OF COLUMBIA None None Corporation true Joseph Amprey III 915 S. Eaton St. Baltimore MD MARYLAND 21224 Executive Officer Director Ben Auspitz 915 S. Eaton St. Baltimore MD MARYLAND 21224 Director Jodi Jahic 915 S. Eaton St. Baltimore MD MARYLAND 21224 Director Biotechnology Decline to Disclose 06b false 2025-04-02 false true false 0 5333250 4299420 1033830 false 10 0 0 0 false Zero Point Five Therapeutics, Inc. /s/ Joseph Amprey III Joseph Amprey III CEO 2025-04-17